Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
|
3 Months Ended | 9 Months Ended | 124 Months Ended | |||
---|---|---|---|---|---|---|
Feb. 28, 2014
|
Feb. 28, 2013
|
Feb. 28, 2014
|
Feb. 28, 2013
|
Feb. 28, 2014
|
May 31, 2013
|
|
Class of Stock [Line Items] | ||||||
Net loss | $ (3,274,397) | $ (2,359,107) | $ (9,435,541) | $ (7,082,759) | $ (41,836,448) | |
Accumulated deficit | (43,438,360) | (43,438,360) | (43,438,360) | |||
Insurance coverage, per depositor at each financial | 250,000 | 250,000 | 250,000 | 250,000 | ||
Deposit in excess of federally insured limits | 7,464,000 | 7,464,000 | 7,464,000 | 386,000 | ||
Estimated future unvested option forfeitures | 0.00% | |||||
Deferred offering costs | 68,292 | 68,292 | 68,292 | 96,930 | ||
Direct costs associated with the convertible notes | 120,000 | |||||
Amortization of deferred offering costs | 3,332 | 120,000 | 120,000 | |||
Common stock options and warrants to purchase | 95,100 | 95,100 | 95,100 | 95,100 | ||
Common stock options and warrants to purchase | 31,970,327 | 18,038,297 | ||||
Face amount of notes | 7,221,250 | 7,221,250 | 7,221,250 | 6,588,250 | ||
Additional common shares if convertible debt is converted to common stock | 6,028,333 | |||||
Unrecognized benefits | 0 | 0 | 0 | 0 | 0 | |
Convertible Debt
|
||||||
Class of Stock [Line Items] | ||||||
Face amount of notes | 4,521,250 | 4,521,250 | 4,521,250 | |||
Equity Securities
|
||||||
Class of Stock [Line Items] | ||||||
Deferred offering costs | 2,084,000 | 2,084,000 | 2,084,000 | |||
Stock Rescission Liability
|
||||||
Class of Stock [Line Items] | ||||||
Deferred offering costs | $ 68,300 | $ 68,300 | $ 68,300 | $ 97,000 | ||
Series B convertible preferred stock
|
||||||
Class of Stock [Line Items] | ||||||
Common stock options and warrants to purchase | 95,100 | 95,100 | 95,100 | |||
Common shares issued upon conversion of preferred stock | 951,000 |